Hereditary Angioedema

Intellia To Test Second CRISPR Therapeutic In Hereditary Angioedema Patients

NICE Recommends BioCryst's Hereditary Angioedema Med

FDA Lifts Clinical Hold On KalVista's Hereditary Angioedema Trial

NICE Recommends BioCryst's Hereditary Angioedema Med

FDA Lifts Clinical Hold On KalVista's Hereditary Angioedema Trial

BioCryst Shares 96-Week Orladeyo Data Highlighting 80% Reduction In HAE Attacks

BioCryst's Orladeyo Application Under Review In Israel For Hereditary Angioedema

BioCryst Shares 96-Week Orladeyo Data Highlighting 80% Reduction In HAE Attacks

BioCryst's Orladeyo Application Under Review In Israel For Hereditary Angioedema

KalVista Stock Falls After FDA Institutes Clinical Hold On Hereditary Angioedema Trial With KVD824

Ionis Pharma's Ligand-Conjugated Antisense Hits Primary Endpoint Goal In Hereditary Angioedema Study

Hereditary Angioedema Recent News

BioCryst's Orladeyo Wins EU Positive Opinion For Hereditary Angioedema

Investors Cheer Positive Data From KalVista's KVD900 Mid-Stage Hereditary Angioedema Trial

BioCryst Pharmaceuticals Is Plummeting 65%